The purpose of these studies was to study patients with abnormal host defense. In FY '91 studies focused mostly on patients with abnormal phagocytic cell function. Particular emphasis was given to patients with chronic granulomatous disease of childhood (CGD), who are the subject of intense study in the Laboratory of Host Defenses. Some of the clinical observations that were made this year included the following: Demonstration of invasive infection with Sarcinosporon inkin in a patient with CHD; demonstration that normal and abnormal neutrophils can cooperate to damage Aspergillus fumigatus, an observation with important clinical implications for use of white cell transfusions in CGD; demonstration that patients with CGD receiving long term prophylaxis with trimethoprim-sulfamethoxazole have reduced frequency of infection against catalase positive bacteria without increased incidence of fungal infection; completion of long term reviews of skeletal involvement by infection in CGD and anesthesia considerations in CGD; the clinical efficacy of in Gamma-interferon in CGD was demonstrated. We continue to monitor and expand these cohorts of patients as well as patients with leukocyte adhesion deficiency and the syndrome of hyperimmunoglobulin-E and recurrent infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000155-16
Application #
3803099
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Sobhanie, Mahdee; Matsuoka, Yumiko; Jegaskanda, Sinthujan et al. (2016) Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). J Infect Dis 213:922-9
O'Donnell, Christopher D; Vogel, Leatrice; Matsuoka, Yumiko et al. (2014) The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol 88:12374-84
Baz, Mariana; Luke, Catherine J; Cheng, Xing et al. (2013) H5N1 vaccines in humans. Virus Res 178:78-98
Talaat, Kawsar R; Karron, Ruth A; Luke, Catherine J et al. (2011) An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine 29:3144-8
Kuhns, Douglas B; Alvord, W Gregory; Heller, Theo et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600-10
Talaat, Kawsar R; Karron, Ruth A; Callahan, Karen A et al. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:3744-53
Karron, Ruth A; Talaat, Kawsar; Luke, Catherine et al. (2009) Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 27:4953-60
Suguitan Jr, Amorsolo L; Marino, Michael P; Desai, Purvi D et al. (2009) The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395:280-8
Zarember, Kol A; Cruz, Anna R; Huang, Chiung-Yu et al. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 53:2654-6
De Ravin, Suk See; Shum, Elaine; Zarember, Kol A et al. (2008) Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone. J Pediatr Endocrinol Metab 21:1057-63

Showing the most recent 10 out of 30 publications